Treatment of gastrointestinal sphincters spasms with botulinum toxin A

Toxins

Volumn 7, Issue 6, 2015, Pages 1882-1916

  Brisinda, Giuseppe ^a   Sivestrini, Nicola ^a   Bianco, Giuseppe ^a   Maria, Giorgio ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Anus; Autonomic nervous system diseases; Biliary diseases; Botulinum toxin; Chronic constipation; Enteric nervous system; Esophageal achalasia; Esophageal diseases; Exocytosis; Fissure in ano; Gastric emptying; Gastrointestinal motility; Membrane fusion; Membrane proteins; Neuromuscular agents; Obesity; Pain; Physiopathology; Spasm; Therapeutic use

Indexed keywords

BOTULINUM TOXIN A; PLACEBO;

ANUS FISSURE; CHAGAS DISEASE; CHRONIC ANAL PAIN; CRICOPHARYNGEAL DYSPHAGIA; CRICOPHARYNGEUS MUSCLE; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG EFFICACY; DRUG SAFETY; DYSPHAGIA; ELECTOMYOGRAPHY; ESOPHAGUS ACHALASIA; ESOPHAGUS SPASM; GASTROINTESTINAL SPHINCTER SPASM; HEMORRHOIDECTOMY; HUMAN; META ANALYSIS (TOPIC); MORTALITY; MYOTOMY; OBESITY; PELVIC FLOOR DYSSYNERGIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; SCORING SYSTEM; STOMACH PARESIS; TREATMENT RESPONSE; VATER PAPILLA STENOSIS; ANIMAL; DRUG EFFECTS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; PATHOPHYSIOLOGY; SPASM;

ANIMALS; BOTULINUM TOXINS, TYPE A; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; SPASM;

EID: 84931287965     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins7061882     Document Type: Review

References (211)

1. Scott, A.B.; Rosenbaum, A.; Collins, C.C. Pharmacologic weakening of extraocular muscles. Investig. Ophthalmol. 1973, 12, 924-927.
2. Maria, G.; Sganga, G.; Civello, I.M.; Brisinda, G. Botulinum neurotoxin and other treatments for fissure-in-ano and pelvic floor disorders. Br. J. Surg. 2002, 89, 950-961.
3. Brisinda, G.; Civello, I.M.; Albanese, A.; Maria, G. Gastrointestinal smooth muscles and sphincters spasms: Treatment with botulinum neurotoxin. Curr. Med. Chem. 2003, 10, 603-623.
4. Bhutani, M.S. Gastrointestinal uses of botulinum toxin. Am. J. Gastroenterol. 1997, 92, 929-933.
5. Pasricha, P.J.; Ravich, W.J.; Hendrix, T.R.; Sostre, S.; Jones, B.; Kalloo, A.N. Intrasphincteric botulinum toxin for the treatment of achalasia. N. Engl. J. Med. 1995, 332, 774-778.
6. Maria, G.; Cassetta, E.; Gui, D.; Brisinda, G.; Bentivoglio, A.R.; Albanese, A. A comparison of botulinum toxin and saline for the treatment of chronic anal fissure. N. Engl. J. Med. 1998, 338, 217-220.
7. 2+-independent signaling mechanism. J. Appl. Physiol. (1985) 2002, 93, 1907-1917.
8. Albanese, A.; Brisinda, G.; Mathias, C.J. The autonomic nervous system and gastrointestinal disorders. In Handbook of Clinical Neurology; Appenzeller, O., Vinken, P.J., Bruyn, G.W., Eds.; Elsevier Science BV: Amsterdam, The Netherlands, 2000; Volume 75, pp. 613-663.
9. Poulain, B.; Tauc, L.; Maisey, E.A.; Wadsworth, J.D.; Mohan, P.M.; Dolly, J.O. Neurotransmitter release is blocked intracellularly by botulinum neurotoxin, and this requires uptake of both toxin polypeptides by a process mediated by the larger chain. Proc. Natl. Acad. Sci. USA 1988, 85, 4090-4094.
10. Grumelli, C.; Corradini, I.; Matteoli, M.; Verderio, C. Intrinsic calcium dynamics control botulinum toxin a susceptibility in distinct neuronal populations. Cell Calcium 2010, 47, 419-424.
11. Akaike, N.; Shin, M.C.; Wakita, M.; Torii, Y.; Harakawa, T.; Ginnaga, A.; Kato, K.; Kaji, R.; Kozaki, S. Transsynaptic inhibition of spinal transmission by a2 botulinum toxin. J. Physiol. 2013, 591, 1031-1043.
12. Mariotti, R.; Bentivoglio, M. Botulinum toxin induces nitric oxide synthase activity in motoneurons. Neurosci. Lett. 1996, 219, 25-28.
13. Lepiarczyk, E.; Bossowska, A.; Majewski, M. Changes in chemical coding of sympathetic chain ganglia (schg) neurons supplying porcine urinary bladder after botulinum toxin (btx) treatment. Cell Tissue Res. 2015, 360, 263-272.
14. Miftakhov, R.N.; Wingate, D.L. Mathematical modelling of the enteric nervous network. Ii: Facilitation and inhibition of the cholinergic transmission. J. Biomed. Eng. 1993, 15, 311-318.
15. Wonnacott, S.; Marchbanks, R.M.; Fiol, C. Ca2+ uptake by synaptosomes and its effect on the inhibition of acetylcholine release by botulinum toxin. J. Neurochem. 1978, 30, 1127-1134.
16. Hansen, M.B. The enteric nervous system iii: A target for pharmacological treatment. Pharmacol. Toxicol. 2003, 93, 1-13.
17. Lourenssen, S.; Miller, K.G.; Blennerhassett, M.G. Discrete responses of myenteric neurons to structural and functional damage by neurotoxins in vitro. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 297, G228-G239.
18. Kelly, E.A.; Koszewski, I.J.; Jaradeh, S.S.; Merati, A.L.; Blumin, J.H.; Bock, J.M. Botulinum toxin injection for the treatment of upper esophageal sphincter dysfunction. Ann. Otol. Rhinol. Laryngol. 2013, 122, 100-108.
19. Chavez, Y.H.; Ciarleglio, M.M.; Clarke, J.O.; Nandwani, M.; Stein, E.; Roland, B.C. Upper esophageal sphincter abnormalities: Frequent finding on high-resolution esophageal manometry and associated with poorer treatment response in achalasia. J. Clin. Gastroenterol. 2015, 49, 17-23.
20. Regan, J.; Murphy, A.; Chiang, M.; McMahon, B.P.; Coughlan, T.; Walshe, M. Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disorders. Cochrane Database Syst. Rev. 2014, 5, CD009968.
21. Kuhn, M.A.; Belafsky, P.C. Management of cricopharyngeus muscle dysfunction. Otolaryngol. Clin. North Am. 2013, 46, 1087-1099.
22. Drendel, M.; Carmel, E.; Kerimis, P.; Wolf, M.; Finkelstein, Y. Cricopharyngeal achalasia in children: Surgical and medical treatment. Isr. Med. Assoc. J. 2013, 15, 430-433.
23. Terre, R.; Panades, A.; Mearin, F. Botulinum toxin treatment for oropharyngeal dysphagia in patients with stroke. Neurogastroenterol. Motil. 2013, 25, 896-e702.
24. Kelly, J.H. Management of upper esophageal sphincter disorders: Indications and complications of myotomy. Am. J. Med. 2000, 108, 43S-46S.
25. Schneider, I.; Thumfart, W.F.; Pototschnig, C.; Eckel, H.E. Treatment of dysfunction of the cricopharyngeal muscle with botulinum a toxin: Introduction of a new, noninvasive method. Ann. Otol. Rhinol. Laryngol. 1994, 103, 31-35.
26. Blitzer, A.; Brin, M.F. Use of botulinum toxin for diagnosis and management of cricopharyngeal achalasia. Otolaryngol. Head Neck Surg. 1997, 116, 328-330.
27. Atkinson, S.I.; Rees, J. Botulinum toxin for cricopharyngeal dysphagia: Case reports of ct-guided injection. J. Otolaryngol. 1997, 26, 273-276.
28. Alberty, J.; Oelerich, M.; Ludwig, K.; Hartmann, S.; Stoll, W. Efficacy of botulinum toxin a for treatment of upper esophageal sphincter dysfunction. Laryngoscope 2000, 110, 1151-1156.
29. Shaw, G.Y.; Searl, J.P. Botulinum toxin treatment for cricopharyngeal dysfunction. Dysphagia 2001, 16, 161-167.
30. Haapaniemi, J.J.; Laurikainen, E.A.; Pulkkinen, J.; Marttila, R.J. Botulinum toxin in the treatment of cricopharyngeal dysphagia. Dysphagia 2001, 16, 171-175.
31. Moerman, M.; Callier, Y.; Dick, C.; Vermeersch, H. Botulinum toxin for dysphagia due to cricopharyngeal dysfunction. Eur. Arch. Otorhinolaryngol. 2002, 259, 1-3.
32. Parameswaran, M.S.; Soliman, A.M. Endoscopic botulinum toxin injection for cricopharyngeal dysphagia. Ann. Otol. Rhinol. Laryngol. 2002, 111, 871-874.
33. Zaninotto, G.; Marchese Ragona, R.; Briani, C.; Costantini, M.; Rizzetto, C.; Portale, G.; Zanetti, L.; Masiero, S.; Costantino, M.; Nicoletti, L.; et al. The role of botulinum toxin injection and upper esophageal sphincter myotomy in treating oropharyngeal dysphagia. J. Gastrointest. Surg. 2004, 8, 997-1006.
34. Murry, T.; Wasserman, T.; Carrau, R.L.; Castillo, B. Injection of botulinum toxin A for the treatment of dysfunction of the upper esophageal sphincter. Am. J. Otolaryngol. 2005, 26, 157-162.
35. Kim, D.Y.; Park, C.I.; Ohn, S.H.; Moon, J.Y.; Chang, W.H.; Park, S.W. Botulinum toxin type A for poststroke cricopharyngeal muscle dysfunction. Arch. Phys. Med. Rehabil. 2006, 87, 1346-1351.
36. Restivo, D.A.; Marchese-Ragona, R.; Lauria, G.; Squatrito, S.; Gullo, D.; Vigneri, R. Botulinum toxin treatment for oropharyngeal dysphagia associated with diabetic neuropathy. Diabetes Care 2006, 29, 2650-2653.
37. Alfonsi, E.; Merlo, I.M.; Ponzio, M.; Montomoli, C.; Tassorelli, C.; Biancardi, C.; Lozza, A.; Martignoni, E. An electrophysiological approach to the diagnosis of neurogenic dysphagia: Implications for botulinum toxin treatment. J. Neurol. Neurosurg. Psychiatry 2010, 81, 54-60.
38. Restivo, D.A.; Marchese-Ragona, R.; Patti, F.; Solaro, C.; Maimone, D.; Zappala, G.; Pavone, A. Botulinum toxin improves dysphagia associated with multiple sclerosis. Eur. J. Neurol. 2011, 18, 486-490.
39. Moerman, M.B. Cricopharyngeal botox injection: Indications and technique. Curr. Opin. Otolaryngol. Head Neck Surg. 2006, 14, 431-436.
40. Allen, J.; White, C.J.; Leonard, R.; Belafsky, P.C. Effect of cricopharyngeus muscle surgery on the pharynx. Laryngoscope 2010, 120, 1498-1503.
41. Hussain, S.Z.; Thomas, R.; Tolia, V. A review of achalasia in 33 children. Dig. Dis. Sci. 2002, 47, 2538-2543.
42. Scholes, M.A.; McEvoy, T.; Mousa, H.; Wiet, G.J. Cricopharyngeal achalasia in children: Botulinum toxin injection as a tool for diagnosis and treatment. Laryngoscope 2014, 124, 1475-1480.
43. Shogan, A.N.; Rogers, D.J.; Hartnick, C.J.; Kerschner, J.E. Use of botulinum toxin in pediatric otolaryngology and laryngology. Int. J. Pediatr. Otorhinolaryngol. 2014, 78, 1423-1425.
44. Huoh, K.C.; Messner, A.H. Cricopharyngeal achalasia in children: Indications for treatment and management options. Curr. Opin. Otolaryngol. Head Neck Surg. 2013, 21, 576-580.
45. Woltman, T.A.; Pellegrini, C.A.; Oelschlager, B.K. Achalasia. Surg. Clin. N. Am. 2005, 85, 483-493.
46. Tack, J.; Zaninotto, G. Therapeutic options in oesophageal dysphagia. Nat. Rev. Gastroenterol. Hepatol. 2015, doi:10.1038/nrgastro.2015.45.
47. Maradey-Romero, C.; Gabbard, S.; Fass, R. Treatment of esophageal motility disorders based on the Chicago classification. Curr. Treat. Options Gastroenterol. 2014, 12, 441-455.
48. Marjoux, S.; Brochard, C.; Roman, S.; Gincul, R.; Pagenault, M.; Ponchon, T.; Ropert, A.; Mion, F. Botulinum toxin injection for hypercontractile or spastic esophageal motility disorders: May high-resolution manometry help to select cases? Dis. Esophagus 2014, doi:10.1111/dote.12282.
49. Vela, M.F. Management strategies for achalasia. Neurogastroenterol. Motil. 2014, 26, 1215-1221.
50. Mabvuure, N.T.; Hey, S.Y.; Forshaw, M. Recurrent respiratory distress and cardiopulmonary arrest caused by megaoesophagus secondary to achalasia. Int. J. Surg. Case Rep. 2014, 5, 628-632.
51. Patti, M.G.; Fisichella, P.M. Controversies in management of achalasia. J. Gastrointest. Surg. 2014, 18, 1705-1709.
52. Leyden, J.E.; Moss, A.C.; MacMathuna, P. Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia. Cochrane Database Syst. Rev. 2014, 12, CD005046.
53. Jung, H.E.; Lee, J.S.; Lee, T.H.; Kim, J.N.; Hong, S.J.; Kim, J.O.; Kim, H.G.; Jeon, S.R.; Cho, J.Y. Long-term outcomes of balloon dilation versus botulinum toxin injection in patients with primary achalasia. Korean J. Intern. Med. 2014, 29, 738-745.
54. Kim do, H.; Jung, H.Y. The long-term outcome of balloon dilation versus botulinum toxin injection in patients with primary achalasia. Korean J. Intern. Med. 2014, 29, 727-729.
55. Annese, V.; Basciani, M.; Perri, F.; Lombardi, G.; Frusciante, V.; Simone, P.; Andriulli, A.; Vantrappen, G. Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia. Gastroenterology 1996, 111, 1418-1424.
56. Fiorini, A.; Corti, R.E.; Valero, J.L.; Bai, J.C.; Boerr, L. Botulinum toxin is effective in the short-term treatment of esophageal achalasia. Preliminary results of a randomized trial. Acta Gastroenterol. Latinoam. 1996, 26, 155-157.
57. Pasricha, P.J.; Rai, R.; Ravich, W.J.; Hendrix, T.R.; Kalloo, A.N. Botulinum toxin for achalasia: Long-term outcome and predictors of response. Gastroenterology 1996, 110, 1410-1415.
58. Fishman, V.M.; Parkman, H.P.; Schiano, T.D.; Hills, C.; Dabezies, M.A.; Cohen, S.; Fisher, R.S.; Miller, L.S. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Am. J. Gastroenterol. 1996, 91, 1724-1730.
59. Cuilliere, C.; Ducrotte, P.; Zerbib, F.; Metman, E.H.; de Looze, D.; Guillemot, F.; Hudziak, H.; Lamouliatte, H.; Grimaud, J.C.; Ropert, A.; et al. Achalasia: Outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut 1997, 41, 87-92.
60. Kolbasnik, J.; Waterfall, W.E.; Fachnie, B.; Chen, Y.; Tougas, G. Long-term efficacy of botulinum toxin in classical achalasia: A prospective study. Am. J. Gastroenterol. 1999, 94, 3434-3439.
61. Annese, V.; Bassotti, G.; Coccia, G.; D'Onofrio, V.; Gatto, G.; Repici, A.; Andriulli, A. Comparison of two different formulations of botulinum toxin A for the treatment of oesophageal achalasia. The gismad achalasia study group. Aliment. Pharmacol. Ther. 1999, 13, 1347-1350.
62. Muehldorfer, S.M.; Schneider, T.H.; Hochberger, J.; Martus, P.; Hahn, E.G.; Ell, C. Esophageal achalasia: Intrasphincteric injection of botulinum toxin a versus balloon dilation. Endoscopy 1999, 31, 517-521.
63. Greaves, R.R.; Mulcahy, H.E.; Patchett, S.E.; Gorard, D.A.; Fairclough, P.D.; Alstead, E.M.; Farthing, M.J. Early experience with intrasphincteric botulinum toxin in the treatment of achalasia. Aliment. Pharmacol. Ther. 1999, 13, 1221-1225.
64. Wehrmann, T.; Kokabpick, H.; Jacobi, V.; Seifert, H.; Lembcke, B.; Caspary, W.F. Long-term results of endoscopic injection of botulinum toxin in elderly achalasic patients with tortuous megaesophagus or epiphrenic diverticulum. Endoscopy 1999, 31, 352-358.
65. Hurwitz, M.; Bahar, R.J.; Ament, M.E.; Tolia, V.; Molleston, J.; Reinstein, L.J.; Walton, J.M.; Erhart, N.; Wasserman, D.; Justinich, C.; et al. Evaluation of the use of botulinum toxin in children with achalasia. J. Pediatr. Gastroenterol. Nutr. 2000, 30, 509-514.
66. Annese, V.; Bassotti, G.; Coccia, G.; Dinelli, M.; D'Onofrio, V.; Gatto, G.; Leandro, G.; Repici, A.; Testoni, P.A.; Andriulli, A. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. Gismad achalasia study group. Gut 2000, 46, 597-600.
67. Mikaeli, J.; Fazel, A.; Montazeri, G.; Yaghoobi, M.; Malekzadeh, R. Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia. Aliment. Pharmacol. Ther. 2001, 15, 1389-1396.
68. Allescher, H.D.; Storr, M.; Seige, M.; Gonzales-Donoso, R.; Ott, R.; Born, P.; Frimberger, E.; Weigert, N.; Stier, A.; Kurjak, M.; et al. Treatment of achalasia: Botulinum toxin injection vs. Pneumatic balloon dilation. A prospective study with long-term follow-up. Endoscopy 2001, 33, 1007-1017.
69. Ghoshal, U.C.; Chaudhuri, S.; Pal, B.B.; Dhar, K.; Ray, G.; Banerjee, P.K. Randomized controlled trial of intrasphincteric botulinum toxin a injection versus balloon dilatation in treatment of achalasia cardia. Dis. Esophagus 2001, 14, 227-231.
70. Zarate, N.; Mearin, F.; Baldovino, F.; Armengol, J.R.; Malagelada, J.R. Achalasia treatment in the elderly: Is botulinum toxin injection the best option? Eur. J. Gastroenterol. Hepatol. 2002, 14, 285-290.
71. D'Onofrio, V.; Miletto, P.; Leandro, G.; Iaquinto, G. Long-term follow-up of achalasia patients treated with botulinum toxin. Dig. Liver Dis. 2002, 34, 105-110.
72. Neubrand, M.; Scheurlen, C.; Schepke, M.; Sauerbruch, T. Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin. Endoscopy 2002, 34, 519-523.
73. Brant, C.; Moraes-Filho, J.P.; Siqueira, E.; Nasi, A.; Libera, E.; Morais, M.; Rohr, M.; Macedo, E.P.; Alonso, G.; Ferrari, A.P. Intrasphincteric botulinum toxin injection in the treatment of chagasic achalasia. Dis. Esophagus 2003, 16, 33-38.
74. Bansal, R.; Nostrant, T.T.; Scheiman, J.M.; Koshy, S.; Barnett, J.L.; Elta, G.H.; Chey, W.D. Intrasphincteric botulinum toxin versus pneumatic balloon dilation for treatment of primary achalasia. J. Clin. Gastroenterol. 2003, 36, 209-214.
75. Martinek, J.; Siroky, M.; Plottova, Z.; Bures, J.; Hep, A.; Spicak, J. Treatment of patients with achalasia with botulinum toxin: A multicenter prospective cohort study. Dis. Esophagus 2003, 16, 204-209.
76. Vela, M.F.; Richter, J.E.; Wachsberger, D.; Connor, J.; Rice, T.W. Complexities of managing achalasia at a tertiary referral center: Use of pneumatic dilatation, heller myotomy, and botulinum toxin injection. Am. J. Gastroenterol. 2004, 99, 1029-1036.
77. Zaninotto, G.; Annese, V.; Costantini, M.; Del Genio, A.; Costantino, M.; Epifani, M.; Gatto, G.; D'Onofrio, V.; Benini, L.; Contini, S.; et al. Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia. Ann. Surg. 2004, 239, 364-370.
78. Mikaeli, J.; Yaghoobi, M.; Montazeri, G.; Ansari, R.; Bishehsari, F.; Malekzadeh, R. Efficacy of botulinum toxin injection before pneumatic dilatation in patients with idiopathic achalasia. Dis. Esophagus 2004, 17, 213-217.
79. Dughera, L.; Battaglia, E.; Maggio, D.; Cassolino, P.; Mioli, P.R.; Morelli, A.; Emanuelli, G.; Bassotti, G. Botulinum toxin treatment of oesophageal achalasia in the old old and oldest old: A 1-year follow-up study. Drugs Aging 2005, 22, 779-783.
80. Bassotti, G.; D'Onofrio, V.; Battaglia, E.; Fiorella, S.; Dughera, L.; Iaquinto, G.; Mazzocchi, A.; Morelli, A.; Annese, V. Treatment with botulinum toxin of octo-nonagerians with oesophageal achalasia: A two-year follow-up study. Aliment. Pharmacol. Ther. 2006, 23, 1615-1619.
81. Mikaeli, J.; Bishehsari, F.; Montazeri, G.; Mahdavinia, M.; Yaghoobi, M.; Darvish-Moghadam, S.; Farrokhi, F.; Shirani, S.; Estakhri, A.; Malekzadeh, R. Injection of botulinum toxin before pneumatic dilatation in achalasia treatment: A randomized-controlled trial. Aliment. Pharmacol. Ther. 2006, 24, 983-989.
82. Zhu, Q.; Liu, J.; Yang, C. Clinical study on combined therapy of botulinum toxin injection and small balloon dilation in patients with esophageal achalasia. Dig. Surg. 2009, 26, 493-498.
83. Kroupa, R.; Hep, A.; Dolina, J.; Valek, V.; Matyasova, Z.; Prokesova, J.; Mrazova, J.; Sedmik, J.; Novotny, I. Combined treatment of achalasia-Botulinum toxin injection followed by pneumatic dilatation: Long-term results. Dis. Esophagus 2010, 23, 100-105.
84. Gutschow, C.A.; Tox, U.; Leers, J.; Schafer, H.; Prenzel, K.L.; Holscher, A.H. Botox, dilation, or myotomy? Clinical outcome of interventional and surgical therapies for achalasia. Langenbecks Arch. Surg. 2010, 395, 1093-1099.
85. Bakhshipour, A.; Rabbani, R.; Shirani, S.; Soleimani, H.A.; Mikaeli, J. Comparison of pneumatic dilation with pneumatic dilation plus botulinum toxin for treatment of achalasia. Acta Med. Iran. 2010, 48, 107-110.
86. Porter, R.F.; Gyawali, C.P. Botulinum toxin injection in dysphagia syndromes with preserved esophageal peristalsis and incomplete lower esophageal sphincter relaxation. Neurogastroenterol. Motil. 2011, doi:10.1111/j.1365-2982.2010.01604.x.
87. Ciulla, A.; Cremona, F.; Genova, G.; Maiorana, A.M. Echo-guided injection of botulinum toxin versus blind endoscopic injection in patients with achalasia: Final report. Minerva Gastroenterol. Dietol. 2013, 59, 237-240.
88. Cai, X.B.; Dai, Y.M.; Wan, X.J.; Zeng, Y.; Liu, F.; Wang, D.; Zhou, H. Comparison between botulinum injection and removable covered self-expanding metal stents for the treatment of achalasia. Dig. Dis. Sci. 2013, 58, 1960-1966.
89. Marjoux, S.; Pioche, M.; Benet, T.; Lanne, J.S.; Roman, S.; Ponchon, T.; Mion, F. Fatal mediastinitis following botulinum toxin injection for esophageal spasm. Endoscopy 2013, 45, E405-E406.
90. Burmeister, S. Review of current diagnosis and management of diffuse esophageal spasm, nutcracker esophagus/spastic nutcracker and hypertensive lower esophageal sphincter. Curr. Opin. Otolaryngol. Head Neck Surg. 2013, 21, 543-547.
91. Achem, S.R.; Gerson, L.B. Distal esophageal spasm: An update. Curr. Gastroenterol. Rep. 2013, 15, 325.
92. Sharata, A.; Kurian, A.A.; Dunst, C.M.; Bhayani, N.H.; Reavis, K.M.; Swanstrom, L.L. Peroral endoscopic myotomy (poem) is safe and effective in the setting of prior endoscopic intervention. J. Gastrointest. Surg. 2013, 17, 1188-1192.
93. Vaezi, M.F. Botulinum toxin in nonachalasia motility disorders: A welcomed therapy in an area with limited therapeutic options. Clin. Gastroenterol. Hepatol. 2013, 11, 1122-1124.
94. Vanuytsel, T.; Bisschops, R.; Farre, R.; Pauwels, A.; Holvoet, L.; Arts, J.; Caenepeel, P.; de Wulf, D.; Mimidis, K.; Rommel, N.; et al. Botulinum toxin reduces dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin. Gastroenterol. Hepatol. 2013, 11, 1115-1121.
95. Roman, S.; Kahrilas, P.J. Management of spastic disorders of the esophagus. Gastroenterol. Clin. North Am. 2013, 42, 27-43.
96. Spector, M.E.; Callaway, E.; McKean, E.L.; Prince, M.E. Videofluoroscopic-guided botulinum toxin injections for pharyngoesophageal spasm after total laryngectomy. Laryngoscope 2013, 123, 394-397.
97. Storr, M.; Allescher, H.D.; Rosch, T.; Born, P.; Weigert, N.; Classen, M. Treatment of symptomatic diffuse esophageal spasm by endoscopic injection of botulinum toxin: A prospective study with long term follow-up. Gastrointest. Endosc. 2001, 54, 18A.
98. Storr, M.; Allescher, H.D.; Rosch, T.; Born, P.; Weigert, N.; Classen, M. Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: A prospective study with long-term follow-up. Gastrointest. Endosc. 2001, 54, 754-759.
99. Miller, L.S.; Pullela, S.V.; Parkman, H.P.; Schiano, T.D.; Cassidy, M.J.; Cohen, S.; Fisher, R.S. Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction. Am. J. Gastroenterol. 2002, 97, 1640-1646.
100. Ferrari, A.P., Jr.; Siqueira, E.S.; Brant, C.Q. Treatment of achalasia in chagas' disease with botulinum toxin. N. Engl. J. Med. 1995, 332, 824-825.
101. Brant, C.Q.; Nakao, F.; Ardengh, J.C.; Nasi, A.; Ferrari, A.P., Jr. Echoendoscopic evaluation of botulinum toxin intrasphincteric injections in chagas' disease achalasia. Dis. Esophagus 1999, 12, 37-40.
102. Zepeda-Gomez, S.; Valdovinos-Diaz, M.A. Usefulness of botulinum toxin in gastrointestinal disorders. Rev. Gastroenterol. Mex. 2002, 67, 126-133.
103. Niola, P.; Battaglia, E.; Casabianca, A.; Verna, C.; Biglino, A.; Grassini, M. A case of chagas' disease. Dig. Liver Dis. 2008, 40, 906-907.
104. Herbella, F.A.; Aquino, J.L.; Stefani-Nakano, S.; Artifon, E.L.; Sakai, P.; Crema, E.; Andreollo, N.A.; Lopes, L.R.; de Castro Pochini, C.; Corsi, P.R.; et al. Treatment of achalasia: Lessons learned with chagas' disease. Dis. Esophagus 2008, 21, 461-467.
105. Lacy, B.E.; Crowell, M.D.; Schettler-Duncan, A.; Mathis, C.; Pasricha, P.J. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus. Diabetes Care 2004, 27, 2341-2347.
106. Friedenberg, F.; Gollamudi, S.; Parkman, H.P. The use of botulinum toxin for the treatment of gastrointestinal motility disorders. Dig. Dis. Sci. 2004, 49, 165-175.
107. Rayner, C.K.; Horowitz, M. New management approaches for gastroparesis. Nat. Clin. Pract. Gastroenterol. Hepatol. 2005, 2, 454-462.
108. Bromer, M.Q.; Friedenberg, F.; Miller, L.S.; Fisher, R.S.; Swartz, K.; Parkman, H.P. Endoscopic pyloric injection of botulinum toxin a for the treatment of refractory gastroparesis. Gastrointest. Endosc. 2005, 61, 833-839.
109. Ezzeddine, D.; Jit, R.; Katz, N.; Gopalswamy, N.; Bhutani, M.S. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest. Endosc. 2002, 55, 920-923.
110. Miller, L.S.; Szych, G.A.; Kantor, S.B.; Bromer, M.Q.; Knight, L.C.; Maurer, A.H.; Fisher, R.S.; Parkman, H.P. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am. J. Gastroenterol. 2002, 97, 1653-1660.
111. Tang, D.M.; Friedenberg, F.K. Gastroparesis: Approach, diagnostic evaluation, and management. Dis. Mon. 2011, 57, 74-101.
112. Gil, R.A.; Hwynn, N.; Fabian, T.; Joseph, S.; Fernandez, H.H. Botulinum toxin type a for the treatment of gastroparesis in parkinson's disease patients. Parkinsonism Relat. Disord. 2011, 17, 285-287.
113. Thomas, M.P.; Wilson, C.H.; Nayar, M.; Manus, D.M.; Walker, M.; Shaw, J.; White, S.A. Endoscopic botulinum toxin injection for the treatment of diabetic gastropathy in pancreas and islet-cell transplant patients. Exp. Clin. Transplant. 2012, 10, 168-171.
114. Rodriguez, L.; Rosen, R.; Manfredi, M.; Nurko, S. Endoscopic intrapyloric injection of botulinum toxin a in the treatment of children with gastroparesis: A retrospective, open-label study. Gastrointest. Endosc. 2012, 75, 302-309.
115. Bagheri, R.; Fattahi, S.H.; Haghi, S.Z.; Aryana, K.; Aryanniya, A.; Akhlaghi, S.; Riyabi, F.N.; Sheibani, S. Botulinum toxin for prevention of delayed gastric emptying after esophagectomy. Asian Cardiovasc. Thorac. Ann. 2013, 21, 689-692.
116. Gui, D.; De Gaetano, A.; Spada, P.L.; Viggiano, A.; Cassetta, E.; Albanese, A. Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats. Aliment. Pharmacol. Ther. 2000, 14, 829-834.
117. Rollnik, J.D.; Meier, P.N.; Manns, M.P.; Goke, M. Antral injections of botulinum a toxin for the treatment of obesity. Ann. Intern. Med. 2003, 138, 359-360.
118. Garcia-Compean, D.; Mendoza-Fuerte, E.; Martinez, J.A.; Villarreal, I.; Maldonado, H. Endoscopic injection of botulinum toxin in the gastric antrum for the treatment of obesity. Results of a pilot study. Gastroenterol. Clin. Biol. 2005, 29, 789-791.
119. Coskun, H.; Duran, Y.; Dilege, E.; Mihmanli, M.; Seymen, H.; Demirkol, M.O. Effect on gastric emptying and weight reduction of botulinum toxin-a injection into the gastric antral layer: An experimental study in the obese rat model. Obes. Surg. 2005, 15, 1137-1143.
120. Albani, G.; Petroni, M.L.; Mauro, A.; Liuzzi, A.; Lezzi, G.; Verti, B.; Marzullo, P.; Cattani, L. Safety and efficacy of therapy with botulinum toxin in obesity: A pilot study. J. Gastroenterol. 2005, 40, 833-835.
121. Foschi, D.; Corsi, F.; Lazzaroni, M.; Sangaletti, O.; Riva, P.; La Tartara, G.; Bevilacqua, M.; Osio, M.; Alciati, A.; Bianchi Porro, G.; et al. Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: A randomized, double-blind, controlled study. Int. J. Obes. 2007, 31, 707-712.
122. Topazian, M.; Camilleri, M.; De La Mora-Levy, J.; Enders, F.B.; Foxx-Orenstein, A.E.; Levy, M.J.; Nehra, V.; Talley, N.J. Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: A pilot study. Obes. Surg. 2008, 18, 401-407.
123. Foschi, D.; Lazzaroni, M.; Sangaletti, O.; Corsi, F.; Trabucchi, E.; Bianchi Porro, G. Effects of intramural administration of botulinum toxin a on gastric emptying and eating capacity in obese patients. Dig. Liver Dis. 2008, 40, 667-672.
124. Cardoso, E.S.; Rodrigues, B.M.; Barroso, M.; Menezes, C.J.; Lucena, R.S.; Nora, D.B.; Melo, A. Botulinum toxin type a for the treatment of the spastic equinus foot in cerebral palsy. Pediatr. Neurol. 2006, 34, 106-109.
125. Mittermair, R.; Keller, C.; Geibel, J. Intragastric injection of botulinum toxin a for the treatment of obesity. Obes. Surg. 2007, 17, 732-736.
126. Topazian, M.; Camilleri, M.; Enders, F.T.; Clain, J.E.; Gleeson, F.C.; Levy, M.J.; Rajan, E.; Nehra, V.; Dierkhising, R.A.; Collazo-Clavell, M.L.; et al. Gastric antral injections of botulinum toxin delay gastric emptying but do not reduce body weight. Clin. Gastroenterol. Hepatol. 2013, 11, 145-150.
127. Wiesel, P.H.; Schneider, R.; Dorta, G.; Blum, A.L.; Gillet, M.; Michetti, P. Botulinum toxin for refractory postoperative pyloric spasm. Endoscopy 1997, 29, 132.
128. Saliakellis, E.; Fotoulaki, M. Gastroparesis in children. Ann. Gastroenterol. 2013, 26, 204-211.
129. Martin, J.T.; Federico, J.A.; McKelvey, A.A.; Kent, M.S.; Fabian, T. Prevention of delayed gastric emptying after esophagectomy: A single center's experience with botulinum toxin. Ann. Thorac. Surg. 2009, 87, 1708-1713; discussion 1713-1714.
130. Bai, Y.; Xu, M.J.; Yang, X.; Xu, C.; Gao, J.; Zou, D.W.; Li, Z.S. A systematic review on intrapyloric botulinum toxin injection for gastroparesis. Digestion 2010, 81, 27-34.
131. Kent, M.S.; Pennathur, A.; Fabian, T.; McKelvey, A.; Schuchert, M.J.; Luketich, J.D.; Landreneau, R.J. A pilot study of botulinum toxin injection for the treatment of delayed gastric emptying following esophagectomy. Surg. Endosc. 2007, 21, 754-757.
132. Ballal, M.A.; Sanford, P.A. Physiology of the sphincter of oddi-the present and the future?-Part 1. Saudi J. Gastroenterol. 2000, 6, 129-146.
133. Shrestha, S.; Pasricha, P.J. Chronic visceral right upper quadrant pain without gallstones. Curr. Treat. Options Gastroenterol. 2001, 4, 123-131.
134. Mandal, A.; Robinson, R.J. Indications and efficacy of botulinum toxin in disorders of the gastrointestinal tract. Eur. J. Gastroenterol. Hepatol. 2001, 13, 603-609.
135. Gorelick, A.; Barnett, J.; Chey, W.; Anderson, M.; Elta, G. Botulinum toxin injection after biliary sphincterotomy. Endoscopy 2004, 36, 170-173.
136. Wehrmann, T.; Schmitt, T.H.; Arndt, A.; Lembcke, B.; Caspary, W.F.; Seifert, H. Endoscopic injection of botulinum toxin in patients with recurrent acute pancreatitis due to pancreatic sphincter of oddi dysfunction. Aliment. Pharmacol. Ther. 2000, 14, 1469-1477.
137. Murray, W.R. Botulinum toxin-induced relaxation of the sphincter of oddi may select patients with acalculous biliary pain who will benefit from cholecystectomy. Surg. Endosc. 2011, 25, 813-816.
138. Murray, W.; Kong, S. Botulinum toxin may predict the outcome of endoscopic sphincterotomy in episodic functional post-cholecystectomy biliary pain. Scand. J. Gastroenterol. 2010, 45, 623-627.
139. Brodsky, J.A.; Marks, J.M.; Malm, J.A.; Bower, A.; Ponsky, J.L. Sphincter of oddi injection with botulinum toxin is as effective as endobiliary stent in resolving cystic duct leaks in a canine model. Gastrointest. Endosc. 2002, 56, 849-851.
140. Brisinda, G.; Maria, G.; Bentivoglio, A.R.; Cadeddu, F.; Marniga, G.; Brandara, F.; Albanese, A. Management of bladder, prostatic and pelvic floor disorders. Neurotox. Res. 2006, 9, 161-172.
141. Hallan, R.I.; Williams, N.S.; Melling, J.; Waldron, D.J.; Womack, N.R.; Morrison, J.F. Treatment of anismus in intractable constipation with botulinum a toxin. Lancet 1988, 2, 714-717.
142. Joo, J.S.; Agachan, F.; Wolff, B.; Nogueras, J.J.; Wexner, S.D. Initial north american experience with botulinum toxin type a for treatment of anismus. Dis. Colon Rectum 1996, 39, 1107-1111.
143. Shafik, A.; El-Sibai, O. Botulin toxin in the treatment of nonrelaxing puborectalis syndrome. Dig. Surg. 1998, 15, 347-351.
144. Maria, G.; Brisinda, G.; Bentivoglio, A.R.; Cassetta, E.; Albanese, A. Botulinum toxin in the treatment of outlet obstruction constipation caused by puborectalis syndrome. Dis. Colon Rectum 2000, 43, 376-380.
145. Maria, G.; Brisinda, G.; Bentivoglio, A.R.; Albanese, A.; Sganga, G.; Castagneto, M. Anterior rectocele due to obstructed defecation relieved by botulinum toxin. Surgery 2001, 129, 524-529.
146. Ron, Y.; Avni, Y.; Lukovetski, A.; Wardi, J.; Geva, D.; Birkenfeld, S.; Halpern, Z. Botulinum toxin type-a in therapy of patients with anismus. Dis. Colon Rectum 2001, 44, 1821-1826.
147. Madalinski, M.H.; Slawek, J.; Duzynski, W.; Zbytek, B.; Jagiello, K.; Adrich, Z.; Kryszewski, A. Side effects of botulinum toxin injection for benign anal disorders. Eur. J. Gastroenterol. Hepatol. 2002, 14, 853-856.
148. Albanese, A.; Brisinda, G.; Bentivoglio, A.R.; Maria, G. Treatment of outlet obstruction constipation in parkinson's disease with botulinum neurotoxin a. Am. J. Gastroenterol. 2003, 98, 1439-1440.
149. Cadeddu, F.; Bentivoglio, A.R.; Brandara, F.; Marniga, G.; Brisinda, G.; Maria, G. Outlet type constipation in parkinson's disease: Results of botulinum toxin treatment. Aliment. Pharmacol. Ther. 2005, 22, 997-1003.
150. Maria, G.; Cadeddu, F.; Brandara, F.; Marniga, G.; Brisinda, G. Experience with type a botulinum toxin for treatment of outlet-type constipation. Am. J. Gastroenterol. 2006, 101, 2570-2575.
151. Keshtgar, A.S.; Ward, H.C.; Sanei, A.; Clayden, G.S. Botulinum toxin, a new treatment modality for chronic idiopathic constipation in children: Long-term follow-up of a double-blind randomized trial. J. Pediatr. Surg. 2007, 42, 672-680.
152. Irani, K.; Rodriguez, L.; Doody, D.P.; Goldstein, A.M. Botulinum toxin for the treatment of chronic constipation in children with internal anal sphincter dysfunction. Pediatr. Surg. Int. 2008, 24, 779-783.
153. Farid, M.; El Monem, H.A.; Omar, W.; El Nakeeb, A.; Fikry, A.; Youssef, T.; Yousef, M.; Ghazy, H.; Fouda, E.; El Metwally, T.; et al. Comparative study between biofeedback retraining and botulinum neurotoxin in the treatment of anismus patients. Int. J. Colorectal. Dis. 2009, 24, 115-120.
154. Farid, M.; Youssef, T.; Mahdy, T.; Omar, W.; Moneim, H.A.; El Nakeeb, A.; Youssef, M. Comparative study between botulinum toxin injection and partial division of puborectalis for treating anismus. Int. J. Colorectal. Dis. 2009, 24, 327-334.
155. Keshtgar, A.S.; Ward, H.C.; Clayden, G.S. Transcutaneous needle-free injection of botulinum toxin: A novel treatment of childhood constipation and anal fissure. J. Pediatr. Surg. 2009, 44, 1791-1798.
156. Farid, M.; El Nakeeb, A.; Youssef, M.; Omar, W.; Fouda, E.; Youssef, T.; Thabet, W.; Elmoneum, H.A.; Khafagy, W. Idiopathic hypertensive anal canal: A place of internal sphincterotomy. J. Gastrointest. Surg. 2009, 13, 1607-1613.
157. Ahmadi, J.; Azary, S.; Ashjaei, B.; Paragomi, P.; Khalifeh-Soltani, A. Intrasphincteric botulinum toxin injection in treatment of chronic idiopathic constipation in children. Iran. J. Pediatr. 2013, 23, 574-578.
158. Zhang, Y.; Wang, Z.N.; He, L.; Gao, G.; Zhai, Q.; Yin, Z.T.; Zeng, X.D. Botulinum toxin type-a injection to treat patients with intractable anismus unresponsive to simple biofeedback training. World J. Gastroenterol. 2014, 20, 12602-12607.
159. Albanese, A.; Maria, G.; Bentivoglio, A.R.; Brisinda, G.; Cassetta, E.; Tonali, P. Severe constipation in parkinson's disease relieved by botulinum toxin. Mov. Disord. 1997, 12, 764-766.
160. Christiansen, J.; Bruun, E.; Skjoldbye, B.; Hagen, K. Chronic idiopathic anal pain: Analysis of ultrasonography, pathology, and treatment. Dis. Colon Rectum 2001, 44, 661-665.
161. Lund, J.N.; Scholefield, J.H. Aetiology and treatment of anal fissure. Br. J. Surg. 1996, 83, 1335-1344.
162. Madoff, R.D.; Fleshman, J.W. Aga technical review on the diagnosis and care of patients with anal fissure. Gastroenterology 2003, 124, 235-245.
163. Shawki, S.; Costedio, M. Anal fissure and stenosis. Gastroenterol. Clin. North Am. 2013, 42, 729-758.
164. Maria, G.; Brisinda, D.; Ruggieri, M.P.; Civello, I.M.; Brisinda, G. Identification of anti-endothelial cell antibodies in patients with chronic anal fissure. Surgery 1999, 126, 535-540.
165. Lindsey, I.; Jones, O.M.; Cunningham, C.; Mortensen, N.J. Chronic anal fissure. Br. J. Surg. 2004, 91, 270-279.
166. Gui, D.; Cassetta, E.; Anastasio, G.; Bentivoglio, A.R.; Maria, G.; Albanese, A. Botulinum toxin for chronic anal fissure. Lancet 1994, 344, 1127-1128.
167. Jost, W.H.; Schimrigk, K. Therapy of anal fissure using botulin toxin. Dis. Colon Rectum 1994, 37, 1321-1324.
168. Jost, W.H.; Schimrigk, K. Botulinum toxin in therapy of anal fissure. Lancet 1995, 345, 188-189.
169. Jost, W.H. One hundred cases of anal fissure treated with botulin toxin: Early and long-term results. Dis. Colon Rectum 1997, 40, 1029-1032.
170. Maria, G.; Brisinda, G.; Bentivoglio, A.R.; Cassetta, E.; Gui, D.; Albanese, A. Botulinum toxin injections in the internal anal sphincter for the treatment of chronic anal fissure: Long-term results after two different dosage regimens. Ann. Surg. 1998, 228, 664-669.
171. Minguez, M.; Melo, F.; Espi, A.; Garcia-Granero, E.; Mora, F.; Lledo, S.; Benages, A. Therapeutic effects of different doses of botulinum toxin in chronic anal fissure. Dis. Colon Rectum 1999, 42, 1016-1021.
172. Jost, W.H.; Schrank, B. Repeat botulin toxin injections in anal fissure: In patients with relapse and after insufficient effect of first treatment. Dig. Dis. Sci. 1999, 44, 1588-1589.
173. Brisinda, G.; Maria, G.; Bentivoglio, A.R.; Cassetta, E.; Gui, D.; Albanese, A. A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N. Engl. J. Med. 1999, 341, 65-69.
174. Fernandez Lopez, F.; Conde Freire, R.; Rios Rios, A.; Garcia Iglesias, J.; Cainzos Fernandez, M.; Potel Lesquereux, J. Botulinum toxin for the treatment of anal fissure. Dig. Surg. 1999, 16, 515-518.
175. Maria, G.; Brisinda, G.; Bentivoglio, A.R.; Cassetta, E.; Gui, D.; Albanese, A. Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure. Am. J. Surg. 2000, 179, 46-50.
176. Lysy, J.; Israelit-Yatzkan, Y.; Sestiery-Ittah, M.; Weksler-Zangen, S.; Keret, D.; Goldin, E. Topical nitrates potentiate the effect of botulinum toxin in the treatment of patients with refractory anal fissure. Gut 2001, 48, 221-224.
177. Madalinski, M.H.; Slawek, J.; Zbytek, B.; Duzynski, W.; Adrich, Z.; Jagiello, K.; Kryszewski, A. Topical nitrates and the higher doses of botulinum toxin for chronic anal fissure. Hepatogastroenterology 2001, 48, 977-979.
178. Brisinda, G.; Maria, G.; Sganga, G.; Bentivoglio, A.R.; Albanese, A.; Castagneto, M. Effectiveness of higher doses of botulinum toxin to induce healing in patients with chronic anal fissures. Surgery 2002, 131, 179-184.
179. Mentes, B.B.; Irkorucu, O.; Akin, M.; Leventoglu, S.; Tatlicioglu, E. Comparison of botulinum toxin injection and lateral internal sphincterotomy for the treatment of chronic anal fissure. Dis. Colon Rectum 2003, 46, 232-237.
180. Siproudhis, L.; Sebille, V.; Pigot, F.; Hemery, P.; Juguet, F.; Bellissant, E. Lack of effficacy of botulinum toxin in chronic anal fissure. Aliment. Pharmacol. Ther. 2003, 18, 515-524.
181. Brisinda, G.; Albanese, A.; Cadeddu, F.; Bentivoglio, A.R.; Mabisombi, A.; Marniga, G.; Maria, G. Botulinum neurotoxin to treat chronic anal fissure: Results of a randomized "botox vs. Dysport" controlled trial. Aliment. Pharmacol. Ther. 2004, 19, 695-701.
182. Giral, A.; Memisoglu, K.; Gultekin, Y.; Imeryuz, N.; Kalayci, C.; Ulusoy, N.B.; Tozun, N. Botulinum toxin injection versus lateral internal sphincterotomy in the treatment of chronic anal fissure: A non-randomized controlled trial. BMC Gastroenterol. 2004, 4, 7.
183. Simms, H.N.; McCallion, K.; Wallace, W.; Campbell, W.J.; Calvert, H.; Moorehead, R.J. Efficacy of botulinum toxin in chronic anal fissure. Ir. J. Med. Sci. 2004, 173, 188-190.
184. Lindsey, I.; Cunningham, C.; Jones, O.M.; Francis, C.; Mortensen, N.J. Fissurectomy-botulinum toxin: A novel sphincter-sparing procedure for medically resistant chronic anal fissure. Dis. Colon Rectum 2004, 47, 1947-1952.
185. Arroyo, A.; Perez, F.; Serrano, P.; Candela, F.; Lacueva, J.; Calpena, R. Surgical versus chemical (botulinum toxin) sphincterotomy for chronic anal fissure: Long-term results of a prospective randomized clinical and manometric study. Am. J. Surg. 2005, 189, 429-434.
186. Arroyo, A.; Perez, F.; Serrano, P.; Candela, F.; Calpena, R. Long-term results of botulinum toxin for the treatment of chronic anal fissure: Prospective clinical and manometric study. Int. J. Colorectal. Dis. 2005, 20, 267-271.
187. De Nardi, P.; Ortolano, E.; Radaelli, G.; Staudacher, C. Comparison of glycerine trinitrate and botulinum toxin-a for the treatment of chronic anal fissure: Long-term results. Dis. Colon Rectum 2006, 49, 427-432.
188. Brisinda, G.; Cadeddu, F.; Brandara, F.; Marniga, G.; Maria, G. Randomized clinical trial comparing botulinum toxin injections with 0.2 per cent nitroglycerin ointment for chronic anal fissure. Br. J. Surg. 2007, 94, 162-167.
189. Scholz, T.; Hetzer, F.H.; Dindo, D.; Demartines, N.; Clavien, P.A.; Hahnloser, D. Long-term follow-up after combined fissurectomy and botox injection for chronic anal fissures. Int. J. Colorectal. Dis. 2007, 22, 1077-1081.
190. Witte, M.E.; Klaase, J.M. Botulinum toxin a injection in isdn ointment-resistant chronic anal fissures. Dig. Surg. 2007, 24, 197-201.
191. Festen, S.; Gisbertz, S.S.; van Schaagen, F.; Gerhards, M.F. Blinded randomized clinical trial of botulinum toxin versus isosorbide dinitrate ointment for treatment of anal fissure. Br. J. Surg. 2009, 96, 1393-1399.
192. Nasr, M.; Ezzat, H.; Elsebae, M. Botulinum toxin injection versus lateral internal sphincterotomy in the treatment of chronic anal fissure: A randomized controlled trial. World J. Surg. 2010, 34, 2730-2734.
193. Samim, M.; Twigt, B.; Stoker, L.; Pronk, A. Topical diltiazem cream versus botulinum toxin a for the treatment of chronic anal fissure: A double-blind randomized clinical trial. Ann. Surg. 2012, 255, 18-22.
194. Valizadeh, N.; Jalaly, N.Y.; Hassanzadeh, M.; Kamani, F.; Dadvar, Z.; Azizi, S.; Salehimarzijarani, B. Botulinum toxin injection versus lateral internal sphincterotomy for the treatment of chronic anal fissure: Randomized prospective controlled trial. Langenbecks Arch. Surg. 2012, 397, 1093-1098.
195. Berkel, A.E.; Rosman, C.; Koop, R.; van Duijvendijk, P.; van der Palen, J.; Klaase, J.M. Isosorbide dinitrate ointment vs. botulinum toxin a (dysport) as the primary treatment for chronic anal fissure: A randomized multicentre study. Colorectal. Dis. 2014, 16, O360-O366.
196. Halahakoon, V.C.; Pitt, J.P. Anal advancement flap and botulinum toxin a (bt) for chronic anal fissure (caf). Int. J. Colorectal. Dis. 2014, 29, 1175-1177.
197. Farouk, R. Sphincter-preserving therapy for treating a chronic anal fissure: Long-term outcomes. Ann. Coloproctol. 2014, 30, 132-134.
198. Gandomkar, H.; Zeinoddini, A.; Heidari, R.; Amoli, H.A. Partial lateral internal sphincterotomy versus combined botulinum toxin a injection and topical diltiazem in the treatment of chronic anal fissure: A randomized clinical trial. Dis. Colon Rectum 2015, 58, 228-234.
199. Chen, H.L.; Woo, X.B.; Wang, H.S.; Lin, Y.J.; Luo, H.X.; Chen, Y.H.; Chen, C.Q.; Peng, J.S. Botulinum toxin injection versus lateral internal sphincterotomy for chronic anal fissure: A meta-analysis of randomized control trials. Tech. Coloproctol. 2014, 18, 693-698.
200. Sajid, M.S.; Hunte, S.; Hippolyte, S.; Kiri, V.A.; Maringe, C.; Baig, M.K. Comparison of surgical vs. chemical sphincterotomy using botulinum toxin for the treatment of chronic anal fissure: A meta-analysis. Colorectal. Dis. 2008, 10, 547-552.
201. Brisinda, G.; Cadeddu, F.; Brandara, F.; Marniga, G.; Vanella, S.; Nigro, C.; Maria, G. Botulinum toxin for recurrent anal fissure following lateral internal sphincterotomy. Br. J. Surg. 2008, 95, 774-778.
202. Asim, M.; Lowrie, N.; Stewart, J.; Lolohea, S.; Van Dalen, R. Botulinum toxin versus botulinum toxin with low-dose glyceryltrinitrate for healing of chronic anal fissure: A prospective, randomised trial. N. Z. Med. J. 2014, 127, 80-86.
203. Tranqui, P.; Trottier, D.C.; Victor, C.; Freeman, J.B. Nonsurgical treatment of chronic anal fissure: Nitroglycerin and dilatation versus nifedipine and botulinum toxin. Can. J. Surg. 2006, 49, 41-45.
204. Mishra, R.; Thomas, S.; Maan, M.S.; Hadke, N.S. Topical nitroglycerin versus lateral internal sphincterotomy for chronic anal fissure: Prospective, randomized trial. ANZ J. Surg. 2005, 75, 1032-1035.
205. Nelson, R.L.; Thomas, K.; Morgan, J.; Jones, A. Non surgical therapy for anal fissure. Cochrane Database Syst. Rev. 2012, 2, CD003431.
206. Brisinda, G.; Bianco, G.; Silvestrini, N.; Maria, G. Cost considerations in the treatment of anal fissures. Expert Rev. Pharmacoecon. Outcomes Res. 2014, 14, 511-525.
207. Minkes, R.K.; Langer, J.C. A prospective study of botulinum toxin for internal anal sphincter hypertonicity in children with hirschsprung's disease. J. Pediatr. Surg. 2000, 35, 1733-1736.
208. Han-Geurts, I.J.; Hendrix, V.C.; de Blaauw, I.; Wijnen, M.H.; van Heurn, E.L. Outcome after anal intrasphincteric botox injection in children with surgically treated hirschsprung disease. J. Pediatr. Gastroenterol. Nutr. 2014, 59, 604-607.
209. Basson, S.; Charlesworth, P.; Healy, C.; Phelps, S.; Cleeve, S. Botulinum toxin use in paediatric colorectal surgery. Pediatr. Surg. Int. 2014, 30, 833-838.
210. Patti, R.; Almasio, P.L.; Arcara, M.; Sammartano, S.; Romano, P.; Fede, C.; Di Vita, G. Botulinum toxin vs. Topical glyceryl trinitrate ointment for pain control in patients undergoing hemorrhoidectomy: A randomized trial. Dis. Colon Rectum 2006, 49, 1741-1748.
211. Patti, R.; Arcara, M.; Bonventre, S.; Sammartano, S.; Sparacello, M.; Vitello, G.; Di Vita, G. Randomized clinical trial of botulinum toxin injection for pain relief in patients with thrombosed external haemorrhoids. Br. J. Surg. 2008, 95, 1339-1343.